Neuroprotection in Stroke

Questions: Discounts, Updates etc.

Price: $1,900.00

Publication Date: 2005-01-28

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Stroke is one of the leading causes of death and adult disability worldwide. Nevertheless, acute treatments for stroke are severely limited. Neuroprotective drugs, which boast the ability to halt the ischemic cascade, offer huge hope to sufferers, but as yet, no such compound has received US approval. However, several promising compounds are currently in development.


Scope

  • Overview of the potential size of the ischemic stroke patient population
  • Examination of current clinical practice including diagnosis and both preventative and acute treatment for stroke
  • Evaluation of the opportunity for neuroprotective compounds in the potential treatment of stroke
  • Review of key products currently in development


    • Report Highlights
    Poor patient awareness about the symptoms of stroke and delayed treatment by healthcare providers limits the number of patients eligible for acute treatment.

    Successful neuroprotection is limited by the short window of opportunity for active intervention. A more in-depth understanding of the mechanisms involved in cell injury and death is needed to aid drug development.

    The cascade of cell death is multi-faceted and although simple single target mechanisms have shown some efficacy in pre-clinical trials, a more complex multi targeted approach may prove more successful in patients.


    Reasons to Purchase

  • Gain a top-line overview of the patient potential and current treatment in the stroke market
  • Understand the unmet need of neuroprotection in stroke
  • Evaluate future players in this market

    • Table of Contents

    Other users found this report page using the following search terms: stroke neuroprotection stroke neuroprotection neuroprotective cascade ischemic treatment market semax drugs review

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.